Background
Introduction
Astrocytic tumors are the most common tumors arising in the central nervous system. According to the WHO classification system [1] , infiltrating astrocytic tumors are classified into diffuse astrocytoma (grade II), anaplastic astrocytoma (grade III), and glioblastoma (grade IV). This grading system reflects the biological behavior of astrocytic tumors, with glioblastoma having the poorest prognosis among them. Despite advances in surgery, radiotherapy, and chemotherapy, the prognosis of glioblastoma remains unfavorable, with a reported 2-year survival rate of only 3.3% [2] . Therefore, to eradicate the tumor cells, a better understanding of the pathophysiology of glioblastoma, including the determination of real therapeutic targets, is urgently needed.
Cancer stem cells (CSCs) are a subpopulation of tumor cells with stem-like properties which have self-renewal capacity, can give rise to heterogeneous cells that comprise a tumor [3] , and are thought to be responsible for the tumorigenesis, maintenance, and recurrence of the tumor. In gliomas, glioma stem cells (GSCs) were described [4, 5] and have been analyzed based on their expression of "stem-cell markers" such as CD133 [5] , CD15 [6] , and CD44 [7] or their phenotype of "side population" as evaluated by flow cytometry [8] , but there has been no consensus on the marker phenotypes of GSCs [3, 9] . Therefore, it is possible that there has been no successful visualization of GSCs that are the real culprits determining the poor prognosis of glioblastoma. From the pathophysiological point of view, one of the cardinal characteristics of glioblastoma is intratumoral heterogeneity in microenvironments [10] . For example, a glioblastoma tissue is composed of various regions from well-vascularized areas to severely hypoxic necrotic areas. This microenvironmental heterogeneity has various effects on the properties of tumor cells and consequently influences the pathophysiology of the tumor. It is assumed that GSCs are not distributed randomly in the tumor tissue, but are localized in a specialized niche that confers high tumorigenic potential on tumor cells [3, 11] . Although recent reports have described some evidence for the roles of a perivascular niche [12] and a hypoxic niche [13] in the pathophysiology of glioblastoma, precise in situ visualization and characterization of the niche that harbors GSCs have not been fully established.
Accumulating evidence has highlighted the importance of being in a quiescent state for stem cells of normal adult tissues to maintain their high capacity for tissue repopulation, such as that occurring after bone marrow transplantation [14, 15] . Similarly, as for CSCs, a quiescent subpopulation of tumor cells was reported to be responsible for tumor-propagating capacity in leukemia [16] , pancreatic cancer [17] , breast cancer [18] , melanoma [19] , and glioblastoma [20] . It was also reported, using a mouse model that spontaneously develops a malignant glioma, that a subpopulation of Ki67-negative quiescent tumor cells is responsible for tumor regrowth after chemotherapy [21] . These lines of evidence compelled us to examine histological sections for stem-like tumor cells in a quiescent state, in order to determine the niche harboring the most important cells regulating the behavior of glioblastoma. Increasing evidence has indicated that hypoxia-inducible factor (HIF)-1α, which is a subunit of HIF-1 and a master regulator of the cellular response to tissue hypoxia [22] , is involved in the promotion and maintenance of the stem-cell properties of glioma cells [23] [24] [25] . In addition, we recently demonstrated that the expression of HIF-1α protein at an appropriate level is essential for hematopoietic stem cells (HSCs) to maintain their quiescence and long-term repopulation capacity [26] . Based on these findings, we hypothesized in this study that stem-like glioma cells showing HIF-1α-regulated quiescence are a strong candidate for long-term tumorigenic cells, and we tried to visualize these cells and their niches histologically in clinical tissue samples of astrocytic tumors.
Here, we demonstrated by multi-color immunohistochemical analysis of tissue samples of glioblastoma that HIF-1α-positive (HIF-1α + ) quiescent stem-like tumor cells are characteristically found in the zone between large ischemic necroses and blood vessels, and are closer to the necrotic areas than to the blood vessels. By culturing glioblastoma cell spheroids under hypoxic conditions, we showed that HIF-1α + quiescent stem-like cells emerge in a hypoxia-dependent manner and are associated with an enhanced sphere-forming activity. With these findings, we advocate a new candidate for the GSC niche, the "peri-necrotic niche", which induces a higher tumorigenic potential and consequently regulates the behavior of glioblastomas. 15:6) . In all of these cases, the histological diagnosis was reviewed according to the latest WHO Classification [1] . Neutral buffered formalin-fixed paraffin-embedded sections of tumor tissues were prepared for immunohistochemical analyses. This study was approved by the Institutional Review Board of Yamaguchi University Hospital. Written informed consent was obtained from all of the individual participants included in the study.
Materials and Methods

Clinical tissue samples
Indices of cellular stemness and quiescence
The proteins SOX2 and NANOG were chosen as markers of the stemness of tumor cells, since they are well-known as core transcription factors involved in the self-renewal and pluripotency of embryonic stem cells [27] and were also reported to play critical roles in the tumorigenesis of glioblastoma cells [28, 29] . As an index of cell-cycle quiescence, we used suppressed phosphorylation at the serine (Ser) 2 residue of the C-terminal domain (CTD) of RNA polymerase II. Phosphorylation at the Ser2 residue of the CTD of RNA polymerase II is abbreviated to RNApII-S2P in the present study. The CTD of RNA polymerase II contains heptapeptide repeats of the consensus sequence Tyr1-Ser2-Pro3-Thr4-Ser5-Pro6-Ser7 [30] . Phosphorylation at Ser5 (RNApII-S5P) is required for the initiation of transcription, while RNApII-S2P triggers the productive elongation phase of transcription as well as mRNA processing [30] . A recent report [31] showed that the suppression of RNApII-S2P (RNApII-S2P -/low ) was observed in quiescent stem cells in various normal tissues and suggested that this can be a marker to discriminate stem cells in a quiescent state from proliferating, terminally differentiated, and senescent cells [14, 31] . Positivity for RNApII-S5P was used as an index for the viability of RNApII-S2P -/low cells.
Single-color immunohistochemistry
For primary antibodies other than anti-carbonic anhydrase IX (CA IX) antibody, deparaffinized sections were pretreated for antigen retrieval by boiling in antigen retrieval solution, pH 9 (Nichirei Biosciences, Tokyo, Japan 
Chromogenic multi-color immunohistochemistry
For triple immunostaining for SOX2/HIF-1α/RNApII-S2P or NANOG/HIF-1α/RNApII-S2P in glioma tissues or spheroids, sections were pretreated for antigen retrieval and endogenous peroxidase blocking, and then incubated with anti-SOX2 or anti-NANOG antibody. After the reaction with alkaline phosphatase (AP)-conjugated donkey anti-goat IgG (H+L) antibody (Jackson ImmunoResearch Laboratories, West Grove, PA, USA), color was developed with Vulcan Fast Red (Biocare Medical, Concord, CA, USA). The sections were treated with Denaturing Solution (Biocare Medical) to ensure that the second staining did not cross-react with the first staining. After the sections were incubated successively with anti-HIF-1α antibody and phosphorylationspecific antibody to detect RNApII-S2P, MACH 2 Double Stain 1 (a secondary antibody cocktail containing AP-conjugated goat anti-mouse IgG and HRP-conjugated goat anti-rabbit IgG antibodies; Biocare Medical) was applied. Color was developed with Perma Blue/AP (Diagnostic BioSystems, Pleasanton, CA, USA) for HIF-1α and DAB for RNApII-S2P. For triple immunostaining for estrogen receptor (ER), progesterone receptor (PgR), and Ki-67 in breast cancer tissue, the sections were pretreated as described above and incubated with mouse anti-ERα monoclonal antibody (1:80; clone 1D5; Dako). After the reaction with APconjugated donkey anti-mouse IgG (H+L) antibody (Jackson ImmunoResearch Laboratories), color was developed with Vulcan Fast Red. The sections were treated with Denaturing Solution and then incubated successively with mouse anti-PgR monoclonal antibody (1:100; clone PgR 636; Dako) and rabbit anti-Ki-67 monoclonal antibody. Subsequently, MACH 2 Double Stain 1 was applied, and color was developed with Perma Blue/AP for PgR and DAB for Ki-67.
The staining pattern of each antigen in multi-color immunohistochemistry was validated by comparing it with the staining pattern of the same antigen in single-color immunohistochemistry.
Immunofluorescent staining
Sections were pretreated for antigen retrieval and then incubated with primary antibodies. Secondary antibodies and fluorescent dyes used for multi-color immunofluorescent staining were Eagle's medium/F-12 (Gibco, Life Technologies) supplemented with B-27 supplement (Gibco, Life Technologies), 20 ng/ml epidermal growth factor (Peprotech, Rocky Hill, NJ, USA), and 20 ng/ml basic fibroblast growth factor (Peprotech) [32] (stem cell medium). After the cells were cultured for 3 days, spheroids of 400-800 μm in diameter were formed, and then they were further incubated for 9 or 24 h under normoxic (5% CO 2 and 95% atmospheric air) or hypoxic (5% CO 2 and 5% O 2 balanced with N 2 ) conditions. A multi-gas incubator with an O 2 control system (APM-50DR, ASTEC, Fukuoka, Japan) was used to generate the hypoxic culture conditions.
Sphere formation assay
Sphere formation assay by limiting dilution analysis was performed as described previously [33, 34] . The spheroids were dissociated using 0.25% (w/v) trypsin-ethylenediaminetetraacetic acid (EDTA) solution (Sigma-Aldrich) and mechanically triturated using a 25G needle and syringe until a single cell suspension was achieved. After counting viable cell number by trypan blue exclusion, cells were plated by 2-fold serial dilution, resulting in a range from 1024 to 0.5 cells/well on a pHEMA-coated 96-well plate containing the stem cell medium in octuplicate for each cell density. After culture for 7 days under the normoxic condition, the presence or absence of spheres measuring more than 50 μm in diameter was recorded in each well. Sphereforming efficiency was estimated as described previously [33] .
Statistical analysis
Mann-Whitney U test was used to compare the data from grade II, III, and IV tissue samples. Simple linear regression and Pearson's correlation coefficient were used for the analysis of the relationships between the different parameters recorded in this study. For the experiments using cultured cells, statistical significance was determined by Student's t test.
Results
HIF-1α + quiescent stem-like tumor cells exist as a small subpopulation of human glioblastoma cells
We attempted to identify HIF-1α-regulated quiescent stem-like tumor cells in astrocytoma tissues using the following immunophenotypes as indices: SOX2 + HIF-1α + RNApII-S2P -/low or NANOG + HIF-1α + RNApII-S2P -/low . First, the expression of SOX2, NANOG, HIF-1α, and
RNApII-S2P in glioblastoma tissue was investigated by single-color immunohistochemistry (Fig 1A) . SOX2 and NANOG were immunolocalized to the nuclei of tumor cells with high frequency. Nuclear immunoreactivity for HIF-1α was also detected in a significant number of tumor cells, and these cells were predominantly located adjacent to necrotic areas. The phosphorylation-specific antibody for RNApII-S2P also labeled most of the tumor cell nuclei, but the immunoreactivity was suppressed in tumor cells around necrotic areas. We also examined the expression of CA IX, another marker of cellular hypoxia. CA IX is known as a hypoxiainduced transmembrane enzyme that regulates microenvironmental pH [35, 36] . As shown in S1 Fig, HIF-1α + cells and CA IX + cells were similarly distributed in the zones around necroses.
As a preliminary experiment, to verify the appropriate detection of quiescence with the phosphorylation-specific antibody for RNApII-S2P, the distribution of RNApII-S2P Pearson's correlation coefficient r = 0.64, n = 21, P < 0.01). In contrast, SOX2 + HIF-1α + RNApII-S2P -/low cells could neither be detected around small necroses with pseudopalisading of tumor cells, which is another type of necrosis in glioblastoma tissues [1, 37, 38] (Fig 3A and  3B) , nor in the areas devoid of necrosis (Fig 3C and 3D ). These findings were also confirmed by triple immunofluorescent staining (Fig 4) . Fig 5C) indicates that most SOX2 + HIF-1α + RNApII-S2P -/low cells were localized in the zone between large ischemic necroses and the nearest blood vessels, and were closer to the necrotic side than to the blood vessels. This suggests that the niche harboring HIF-1α-regulated quiescent stemlike tumor cells is present near large ischemic necroses ("peri-necrotic niche"), potentially under the influence of oxygen diffusion from blood vessels. It has been reported that HIF-2α, another member of the HIF family, is implicated in the regulation of stem-like cells in glioma [23] . We compared the localization of SOX2 + HIF-1α Peri-Necrotic Niche in Glioblastoma generate spheroids, and then the spheroids were further cultured for 9 or 24 h under normoxic or hypoxic (5% O 2 ) conditions (Fig 6A) . Under normoxia, cells composing the spheroids were diffusely positive for RNApII-S2P, and negative or weakly positive for HIF-1α (Fig 6E) . Upregulation of HIF-1α was observed in the spheroids maintained under hypoxia for 9 as well as 24 h (Fig 6F and 6G) . As for RNApII-S2P, almost all the constituent cells were RNApII-S2P + following 9 h under hypoxia (Fig 6F) , while RNApII-S2P -/low cells appeared only in the central areas of spheroids after 24 h under hypoxia (Fig 6G) . Triple immunostaining for NANOG, HIF-1α, and RNApII-S2P showed clearly that NANOG + HIF-1α + RNApII-S2P
-/low cells appeared exclusively in the spheroids after 24 h under hypoxia (Fig 6J) . Interestingly, NANOG + HIF-1α + RNApII-S2P -/low cells tended to be localized in the zone between the central core, which must be severely hypoxic, and the superficial zone, which is exposed to 5% O 2 , of the spheroids. This zone containing NANOG + HIF-1α + RNApII-S2P -/low cells is considered a model corresponding to the "peri-necrotic niche" in glioblastoma tissues. We next triturated the spheroids under these 3 conditions to perform a sphere formation assay under normoxic conditions. The sphere-forming efficiency (SFE) of the spheroids after 9 h under hypoxia was comparable to that of normoxic controls, while cells obtained from the spheroids following 24 h under hypoxia showed a significantly (P < 0.05) higher SFE than that of normoxic controls (Fig 6K) . These results demonstrate that the spheroids cultured under 5% O 2 for 24 h gained an enhanced tumorigenic capacity, presumably by generating a moderately hypoxic niche harboring tumor cells of the NANOG + HIF-1α + RNApII-S2P -/low phenotype.
Taken together, these data imply that the "peri-necrotic niche" harboring HIF-1α + quiescent stem-like tumor cells in glioblastoma tissues can be generated in an intratumoral gradient of hypoxia and is associated with an enhanced tumorigenic capacity (Fig 7) .
Discussion
A niche harboring GSCs with a high long-term tumorigenic capacity would represent a target for new therapies to eradicate glioblastoma cells. In the context of the repopulation capacity of normal HSCs, we previously showed that the niche that maintains a moderate level of HIF-1α protein expression is essential for keeping HSCs in a quiescent state, and that these HIF-1α-regulated quiescent HSCs exhibit a high capacity for long-term repopulation after bone marrow transplantation [26] . Since normal tissue stem cells and CSCs tend to share common underlying mechanisms to control their stemness [39] , we applied the concept of HIF-1α-regulated quiescence to GSCs in order to clarify whether a similar niche may play important roles in the pathophysiology of glioblastoma. In the present study, by combining clinical sample analyses with in vitro experiments, we characterized a niche harboring quiescent stem-like tumor cells of the SOX2 + HIF-1α + RNApII-S2P -/low or NANOG + HIF-1α + RNApII-S2P -/low phenotypes, which are associated with an enhanced tumorigenic capacity. Within glioblastoma tissues, this niche was mapped to a location between large ischemic necroses and the nearest blood vessels, and was closer to the necrotic side than to the blood vessels. Since a gradient of oxygen concentration is present between the blood vessels, which have a relatively high oxygen concentration, and the foci of ischemic necrosis, which are under intense hypoxia (Fig 7) , the zone containing SOX2 + (or NANOG + ) HIF-1α + RNApII-S2P -/low cells may be under an appropriate degree of hypoxia for maintaining the expression of HIF-1α protein at a moderate level, which would maintain the tumor cells under a quiescent state and support a higher tumorigenic potential. The hypoxic activation of the HIF-1 pathway in this "peri-necrotic" zone was implied by our finding that HIF-1α, as well as another hypoxia-induced protein, CA IX, were expressed by tumor cells in this zone. This interpretation of the histological data was supported by our in vitro experiments with spheroids, which also have a gradient of oxygen concentration , and then divided into 2 groups (normoxic and hypoxic). After normoxic or hypoxic (5% O 2 ) culture for 9 or 24 h, histological analysis and sphere formation assay under normoxic conditions were performed. Data for the normoxic and between the surface area (which has a relatively high oxygen concentration) and the central core (which is under severe hypoxia) (Fig 7) . -/low cells, was enhanced, while spheroids under 9 h hypoxia, which lacked these cells, showed no significant increase in SFE. Thus, the up-regulation of HIF-1α itself is not sufficient for hypoxic groups sampled after the same culture time were compared. b-j: Histological analysis of the spheroids cultured under normoxic or hypoxic conditions. Since the spheroids of normoxic group cultured for 9 and 24 h showed similar results, only the spheroids cultured for 24 h are shown. H-E staining (b-d), chromogenic double immunostaining for HIF-1α/RNApII-S2P (e-g), and triple immunostaining for NANOG/HIF-1α/RNApII-S2P (h-j) are presented (NANOG, red; HIF-1α, blue; RNApII-S2P, brown). NANOG + HIF-1α + RNApII-S2P -/low cells (purple cells) were detected in spheroids cultured in hypoxia for 24 h (j, arrows). The inset in j shows a higher magnification of these cells. These data are representative of at least 3 independent experiments. Scale bars, 50 μm. k: Sphere-forming efficiency of the cells derived from the spheroids of normoxic or hypoxic groups. Values are relative ones in which the results for the normoxic spheroids sampled after the same culture time were set to 1. The results are expressed as the mean ± SD of at least 7 independent experiments. N.S., not significant; *, P < 0.05. doi:10.1371/journal.pone.0147366.g006 glioblastoma cells to obtain a higher tumorigenic capacity, and the additional induction of quiescence appears to be crucial for this raised tumorigenic capacity to occur. The biological importance of SOX2 + (or NANOG + ) HIF-1α + RNApII-S2P -/low tumor cells was also confirmed by our finding that these cells were found exclusively in glioblastoma tissues but not in grade II-III astrocytoma tissues. Therefore, the presence of the niche harboring these cells might be one aspect of the microenvironmental heterogeneity that is a distinctive feature of glioblastoma. Taken together, it can be concluded that an appropriately hypoxic microenvironment around large ischemic necroses (the "peri-necrotic niche") in glioblastoma provides a niche for stem-like tumor cells associated with high tumorigenic capacity (Fig 7) . In glioblastoma tissues, there are 2 types of necroses, large ischemic necrosis and small pseudopalisading necrosis [1, 37, 38] . The extent of large ischemic necroses has been described as an adverse prognostic factor [40, 41] . This clinicopathological relevance supports our immunohistochemical data, which highlight the importance of large ischemic necroses for providing the "peri-necrotic niche". SOX2 + (or NANOG + ) HIF-1α + RNApII-S2P -/low cells were found in the zones around large ischemic necroses, but not in those around small pseudopalisading necroses. This difference between the 2 types of necroses might reflect the distinct mechanisms underlying their occurrence. Brat et al. proposed that cells around pseudopalisading necroses are composed of tumor cells actively migrating away from a hypoxic focus and showing a higher rate of apoptosis [42] , which is in striking contrast to the cells around large ischemic necroses. In our present study, the cell-cycle status of peri-necrotic tumor cells appeared to be different between the 2 types of necroses. Tumor cells around large ischemic necroses were RNApII-S2P -/low , while cells around small pseudopalisading necroses were RNApII-S2P + .
Thus, although there was a previous report showing that areas around pseudopalisading necroses contain cells positive for CD133, a putative marker for GSCs [43] , it is reasonable to consider that the areas around small pseudopalisading necroses are distinct from the zones around large ischemic necroses that provide a niche for quiescent stem-like tumor cells. Our in vitro data obtained from the analysis of spheroids revealed a close association between the microenvironment-dependent quiescence of glioblastoma cells and an enhanced tumorigenic potential. This implies that glioblastoma cells are flexible in that they become quiescent in hypoxic spheroids but begin to proliferate actively and form tumor spheres efficiently in response to microenvironmental changes. Quiescence is one of the states of the G 0 phase of the cell cycle. Quiescent cells must be distinct from terminally differentiated cells and senescent cells, both of which irreversibly exited from the cell cycle. Quiescence is characterized by the ability of cells to re-enter the cell cycle in response to appropriate stimuli [14] . These quiescent cells can be distinguished from terminally differentiated or senescent cells by their characteristic phosphorylation pattern of RNA polymerase II (RNApII-S2P -/low and RNApII-S5P + ), indicating that transcription is initiated but transcriptional elongation is suppressed [14] . Our immunohistochemical finding that only a small subpopulation of Ki-67 -glioblastoma cells
showed an RNApII-S2P -/low phenotype reflects the difference in the type of G 0 phase between the Ki-67 -cells and RNApII-S2P -/low cells. The former includes not only quiescent cells but also terminally differentiated cells and senescent cells, whereas the latter is specific for quiescent cells. Hypoxia-induced cell-cycle arrest could reportedly be mediated by the action of HIF-1α through the disruption of c-Myc function, suppression of cyclin D expression, and induction of p21 Cip1 [44, 45] . In contrast, little is known about the mechanisms by which HIF-1α concurrently confers stemness on cells.
Accumulating studies have highlighted the perivascular areas in tumors as a candidate for a GSC niche [12, [46] [47] [48] . The importance of the perivascular niche for GSCs is supported by the idea that GSCs must share the same mechanisms as normal neural stem cells, which reside around blood vessels, to promote and maintain their stemness under the influence of paracrine factors secreted by vascular endothelial cells and/or perivascular cells, for example, nitric oxide [46] , sonic hedgehog [48] , and osteopontin [47] . Since perivascular areas are relatively abundant in oxygen and nutrients, these areas are thought to be the microenvironment suitable for cell proliferation. On the other hand, the peri-necrotic niche specified in our study is characterized by a paucity of oxygen and nutrients, which could activate hypoxia-dependent pathways and consequently confer quiescence as well as stemness on tumor cells. Thus, it is probable that stem-like tumor cells in the perivascular niche are closely related to the phenotype of cells in the proliferative state, while those in the peri-necrotic niche show the phenotype of dormant long-term stem-like cells that can be activated to undergo proliferation upon microenvironmental changes.
While several lines of evidence have indicated that HIF-1α mediates the hypoxia-induced promotion of stemness in glioma cells [24, 25] , the implication of HIF-2α in the biology of GSCs has also been demonstrated. Li et al. [23] reported that HIF-2α is preferentially expressed by CD133 + putative GSCs under both hypoxic and normoxic conditions, whereas HIF-1α is induced under hypoxia not only in CD133 + but also in CD133 -glioma cells. Both HIF-1α and HIF-2α have been shown to be crucially involved in the promotion of in vitro sphere formation, cell growth, and the survival of CD133 + glioma cells [23] . To discuss the roles of HIF-2α
in the stemness and quiescence of glioblastoma cells within the peri-necrotic niche, which is the focus of our study, we compared the localization of HIF-2α + cells with that of SOX2 + HIF- [23] . In the context of hypoxia-induced quiescence, an opposing function of HIF-2α to that of HIF-1α is suggested by reports showing that HIF-2α promotes proliferation under hypoxia through c-Myc activation or other mechanisms [49, 50] . Thus, we speculate that SOX2 + HIF-1α + RNApII-S2P -/low cells and HIF-2α + cells might play different roles in the biology of glioblastoma. Although further studies are needed to clarify precisely how HIF-1α and HIF-2α share their contributions to quiescence and tumorigenicity in glioblastomas, it might be true that they are differently used to regulate the behavior of stem-like tumor cells including quiescence, proliferation, and so forth. In summary, the present study highlights the intratumoral areas around large ischemic necroses as a niche that provides an appropriate microenvironment for glioblastoma cells to acquire quiescence and an enhanced tumorigenic potential. This "peri-necrotic niche" would be a promising target for new therapies to eradicate glioblastoma cells and overcome the therapeutic resistance of glioblastomas.
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